CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising number of fertility clinics worldwide
4.1.2. Technological advancements in the field of genetic analysis
4.1.3. High risk of chromosomal abnormalities with advancing maternal age
4.1.4. Declining fertility rates worldwide
4.2. Market Restraints & Challenges
4.2.1. Unfavourable government regulations
4.2.2. Socioethical concerns regarding preimplantation genetic testing
4.3. Market Opportunities
4.3.1. Growing medical tourism
4.3.2. Growth initiatives by key market players
CHAPTER 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET – BY
PROCEDURE TYPE
5.1. Introduction
5.2. Preimplantation genetic screening
5.3. Preimplantation genetic diagnosis
CHAPTER 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET – BY
PRODUCT AND SERVICE
6.1. Introduction
6.2. Instruments
6.3. Reagents and consumables
6.4. Software and services
CHAPTER 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET - BY
TECHNOLOGY
7.1. Introduction
7.2. Polymerase chain reaction
7.3. Next-generation sequencing
7.4. Comparative genomic hybridisation
7.5. Fluorescence in situ hybridisation
7.6. Single-nucleotide polymorphism
CHAPTER 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET - BY
APPLICATION
8.1. Introduction
8.2. Single Gene Disorders
8.3. Structural Chromosomal Abnormalities
8.3.1. Deletions
8.3.2. Translocations
8.3.3. Inversions
8.3.4. Duplications
8.4. Gender Identification
8.5. X-Linked Disorders
8.6. HLA Typing
8.7. Aneuploidy
GLOBAL 9. PREIMPLANTATION GENETIC TESTING MARKET - BY END USER
9.1. Introduction
9.2. Hospitals, diagnostic labs, and service providers
9.3. Maternity centres & fertility clinics
9.4. Research laboratories & academic institutes
CHAPTER 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET - BY
GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET -
COMPANY PROFILES
11.1. Thermo Fisher Scientific, Inc.
11.2. Agilent Technologies Inc.
11.3. Abbott Laboratories.
11.4. Illumina, Inc.
11.5. Bayer Healthcare LLC.
11.6. Natera, Inc.
11.7. Oxford Gene Technology.
11.8. SciGene Corporation.
11.9. Natera, Inc.
11.10. PerkinElmer, Inc.
11.11. Genesis Genetics Ltd.
11.12. Reproductive Genetics Innovations LLC.
11.13. Quest Diagnostics Inc.
11.14. Laboratory Corporation.
CHAPTER 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET –
COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
